Boston Scientific Corporation has completed its $1.75 billion acquisition of heart disease catheter developer Baylis Medical Company. The deal has allowed Boston Scientific to become one of the largest companies to provide a full suite of tools for left atrial auricle closure and atrial fibrillation ablation.